carbostyril has been researched along with Arteriosclerosis, Coronary in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Byerly, MJ; Glick, ID; Hamer, RM; Khan, AY; Lamberti, JS; McEvoy, JP; Nasrallah, HA; Ray, N; Steinbook, RM; Stroup, TS | 1 |
| Cho, KM; Choi, SK; Chung, JO; Jun, CH; Kim, BS; Kim, HS; Kim, TJ; Park, CH; Park, SY; Rew, JS; Son, DJ | 1 |
1 trial(s) available for carbostyril and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of switching from olanzapine, quetiapine, and risperidone to aripiprazole on 10-year coronary heart disease risk and metabolic syndrome status: results from a randomized controlled trial.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Coronary Artery Disease; Dibenzothiazepines; Drug Substitution; Female; Humans; Longitudinal Studies; Male; Metabolic Syndrome; Middle Aged; Multicenter Studies as Topic; Odds Ratio; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Risperidone | 2013 |
1 other study(ies) available for carbostyril and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Risk factors for small bowel bleeding in chronic nonsteroidal anti-inflammatory drug users.
Topics: Aged; Alanine; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Capsule Endoscopy; Coronary Artery Disease; Female; Gastrointestinal Hemorrhage; Humans; Incidence; Intestine, Small; Male; Middle Aged; Platelet Aggregation Inhibitors; Pyridines; Quinolones; Retrospective Studies; Risk Factors | 2015 |